PCR Perspectives

PCR
  • 0.0（0則評分）
  • 醫學
  • 系列

Stay at the forefront of interventions for valvular heart disease, coronary, and structural interventions with expert insights and perspectives. These interviews explore the techniques, tools, and key topics shaping the ever-evolving field of interventional cardiology Hosted on Acast. See acast.com/privacy for more information.

顯示全部

  1. 第 1 集

    How to successfully approach CTO interventions: a step-by-step approach

    Elliot Smith, Thomas Hovasse, and Roberto Garbo present a structured, step-by-step approach to chronic total occlusion (CTO) interventions, starting from angiographic analysis through to strategy selection and technique adaptation. The discussion begins with angiographic assessment, emphasising the importance of identifying key anatomical features upfront. Based on this evaluation, operators determine the most appropriate strategy—typically beginning with an antegrade approach, with readiness to escalate to retrograde or dissection techniques depending on case complexity and progression. The panel outlines essential tools for CTO procedures, including a 7 Fr guiding catheter, various wires (from soft to stiff), and microcatheters, while also addressing how these tools are introduced into routine practice. Attention is given to operator experience, decision-making flexibility, and technique sequencing. In parallel, the importance of progressive skill acquisition is highlighted. Failure is positioned not as an endpoint, but as a learning opportunity—integral to refining technique and gaining confidence. Listen to this discussion for structured guidance on navigating CTOs in a safe and effective way. Hosted on Acast. See acast.com/privacy for more information.

    21 分鐘

  2. 第 2 集

    What are the essential aspects of transcatheter LAA closure?

    In this #europcr 2025 exchange, Ole De Backer and Philippe Garot explore the evolving landscape of transcatheter left atrial appendage (LAA) occlusion. From differences in patient selection on either side of the Atlantic—high bleeding risk in Europe vs. broader indications in the US—to upcoming pivotal trials comparing LAA closure to DOACs, this conversation covers it all. They also break down what defines a state-of-the-art LAA procedure, with an emphasis on pre-procedural imaging (cardiac CT or 3D TEE), and share key insights on post-procedural management, including antithrombotic therapy and follow-up imaging. Hit play for a quick yet comprehensive update on where LAA closure is headed. Hosted on Acast. See acast.com/privacy for more information.

    7 分鐘

  3. 第 3 集

    First guidelines for the treatment of LM disease issued by SOLACI and SIAC

    Cleverson Zukowski and Pablo Lamelas take a moment during #europcr 2025 to shed light on a major regional milestone: the first-ever guidelines for the treatment of left main disease, issued jointly by the Latin American Society of Interventional Cardiology (SOLACI) and the Interamerican Society of Cardiology (SIAC). Why were these guidelines created specifically for Latin America? What are their key recommendations? And how can they be applied in day-to-day practice, especially when deciding between PCI and surgery? Tune in to hear how these guidelines reflect the region’s unique healthcare challenges and may help tailor treatment to the specific needs of Latin American patients. Hosted on Acast. See acast.com/privacy for more information.

    5 分鐘

  4. 第 4 集

    FAITAVI - Major Late-Breaking Trial from EuroPCR 2025

    Stephan Windecker and Flavio Ribichini review the outcomes of the FAITAVI trial, presented during the #europcr 2025 LBT session. As coronary artery disease is the most common cardiac comorbidity in patients undergoing TAVI, the trial set out to evaluate whether physiology-guided decision-making could offer better clarity. When performing diagnostic angiography before TAVI, clinicians often find intermediate coronary lesions that don’t obviously require revascularisation — so what's the right strategy in these cases? FAITAVI is the first randomised trial comparing angiography-guided versus FFR-guided PCI decisions in the TAVI setting. Learn more about the study design, inspired by FAME-1, and how the results support the feasibility and value of FFR measurements in patients with CAD undergoing TAVI. The data also confirm that intermediate lesions can safely be left untreated. Listen to this episode now to understand how these findings could change practice! Hosted on Acast. See acast.com/privacy for more information.

    8 分鐘

  5. 第 5 集

    Vulnerable plaque PCI after PREVENT

    What does the PREVENT trial tell us about managing vulnerable plaques? Recorded during #europcr 2025, this discussion features Michael Haude and Thomas Cuisset as they review key insights from this major study of over 1,600 patients with physiologically non-significant but vulnerable plaques identified by intracoronary imaging—mainly IVUS. Patients were randomised to receive either optimal medical therapy (OMT) alone or combined with preventive PCI, and followed over several years. While the composite endpoint favored the PCI group, the benefit was driven solely by a reduction in target lesion revascularisation—without differences in death or myocardial infarction. Should PCI be systematically performed in such cases? Tune in for a nuanced expert perspective! Hosted on Acast. See acast.com/privacy for more information.

    5 分鐘

  6. 第 6 集

    How to efficiently and safely manage calcified left main disease

    Nicola Ryan and Flavio Ribichini discuss the challenges of treating the calcified left main stem. They break down the complexities of this high-risk condition and highlight the role of mechanical circulatory support in everyday practice. They focus on the role of intracoronary imaging as a game-changer and examine the use of one versus two stents, outlining cases where two stents may be necessary. Key takeaways 1. Calcified left main stem disease is complex but can be simplified with the right tools. 2. Intravascular imaging is crucial for accurate assessment and treatment planning. 3. A careful, step-by-step approach leads to the best angiographic results. Hosted on Acast. See acast.com/privacy for more information.

    9 分鐘

  7. 第 7 集

    How to manage coronary artery disease in TAVI candidates?

    At #EuroPCR2025, Martine Gilard, Antonio Mangieri, and Marco Barbanti share their perspectives on managing coronary artery disease in patients scheduled for TAVI. Is coronary angiography always necessary? When should PCI be performed—before, during, or after the procedure? And how do you decide? Tune in for a practical exchange on strategy, timing, and patient selection! Hosted on Acast. See acast.com/privacy for more information.

    7 分鐘
顯示第 2 季整季（共 7 集）

簡介

Stay at the forefront of interventions for valvular heart disease, coronary, and structural interventions with expert insights and perspectives. These interviews explore the techniques, tools, and key topics shaping the ever-evolving field of interventional cardiology Hosted on Acast. See acast.com/privacy for more information.

資訊

  • 創作者
    PCR
  • 集數
    18
  • 季數
    2
  • 年齡分級
    兒少適宜
  • 版權
    © PCR
  • 節目網站
    PCR Perspectives

你可能也會喜歡